Home
    • Plans Blog Contact
    IQVIA Holdings Inc logo

    IQVIA Holdings Inc

    IQV
    Last price US$209.16
    Market cap US$34.8b
    12M price change 4.10%
    Loading the 12-month Mave Thesis and 1-month news signal

    Industry and sector peers, plus broader research alternatives

    View comparison
    Agilent Technologies IncA Industry peer Thermo Fisher Scientific IncTMO Industry peer Medpace Holdings IncMEDP Industry peer Zoetis IncZTS Sector peer
    Overview Earnings Report Price History News Competitors Earnings per Share Return on Equity Net Margin Share Buyback Leverage Financial Statements Financial Ratio
    Dashboard Funda..tals Prediction Screener Map

    IQVIA Holdings Inc Overview

    Industry: Diagnostics & Research

    Sector: Healthcare

    IQVIA Holdings Inc. engages in the provision of advanced analytics, technology solutions, and clinical research services to the life sciences industry in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions. The Technology & Analytics Solutions segment offers a range of cloud-based applications and related implementation services; real world solutions that enable life sciences and provider customers to generate and disseminate evidence, which informs health care decision making and improves patients' outcomes; and strategic and implementation consulting services, such as advanced analytics and commercial processes outsourcing services. This segment also provides country level performance metrics related to sales of pharmaceutical products, prescribing trends, medical treatment, and promotional activity across various channels, including retail, hospital, and mail order; and measurement of sales or prescribing activity at the regional, zip code, and individual prescriber level. The Research & Development Solutions segment offers project management and clinical monitoring; clinical trial support; strategic planning and design services; and decentralized clinical trials, as well as central laboratory, genomic, bioanalytical, ADME, discovery, and vaccine and biomarker laboratory services. The Contract Sales & Medical Solutions segment provides health care provider and patient engagement services, and scientific strategy and medical affairs services. It serves pharmaceutical, biotechnology, device and diagnostic, and consumer health companies. The company was formerly known as Quintiles IMS Holdings, Inc. and changed its name to IQVIA Holdings Inc. in November 2017. IQVIA Holdings Inc. was incorporated in 2016 and is headquartered in Durham, North Carolina. IQVIA Holdings Inc. engages in the provision of advanced analytics, technology solutions, and clinical research services to the life sciences industry in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Technology & Analytics Solutions, Research & Development S Read More

    Mavefund brings filings, fundamentals, valuation, price history and news for IQVIA Holdings Inc into one research view. The sections below show what strengthens or weakens the research case.

    Score

    Reported Results

    What the company reported, with filing details kept small.

    Filed May 05, 2026

    Quarterly result summary

    Revenue was $4,151M (+8.4% YoY); EPS was $1.61 (reported).

    Revenue $4,151M +8.4% YoY
    EPS $1.61 reported
    Operating income $514M +4% YoY
    Net income $274M reported

    What changed

    • Revenue +8.4% YoY to $4,151M; EPS reported to $1.61.
    • Capital return update: free cash flow $491M.
    • Operating income +4% YoY to $514M.

    Guidance / outlook

    The company expects approximately $8.9 billion of this backlog to convert to revenue in the next twelve months, representing growth of 7.6% year-over-year.

    Earnings release Open filing

    Source: SEC EDGAR company-filed earnings materials. Dates are shown only for verification; review the source filing before relying on extracted report details.

    Other recent earnings materials
    SEC filing 8-K May 05, 2026 SEC filing 10-Q May 05, 2026 SEC filing 10-K Feb 17, 2026 Earnings release Earnings release Feb 05, 2026 SEC filing 8-K Feb 05, 2026 SEC filing 8-K Oct 28, 2025 Earnings release Earnings release Oct 28, 2025 SEC filing 10-Q Oct 28, 2025 Earnings release Earnings release Jul 22, 2025 SEC filing 8-K Jul 22, 2025 SEC filing 10-Q Jul 22, 2025

    Prediction-grade evidence

    Recent News

    Company-relevant articles from sources that pass the Mave Signal relevance and reliability checks.

    Earnings Per Share

    Score 5.00/5
    IQVIA Holdings Inc boasts a high score, as its Earnings Per Share (EPS) has demonstrated consistent growth over the past six years. Notable counterparts in the sector with high scores includes Zoetis Inc Agilent Technologies Inc Thermo Fisher Scientific Inc
    In Diagnostics & Research industry , Agilent Technologies Inc , Thermo Fisher Scientific Inc , Medpace Holdings Inc are companies with high ratings.

    Return on Equity

    Score 4.50/5
    IQVIA Holdings Inc stands out with a superior score in the Return on Equity (ROE) section, surpassing the sector median value and showcasing its strong performance in this metric. The top companies in the same sector include Zoetis Inc Agilent Technologies Inc Thermo Fisher Scientific Inc
    IQVIA Holdin... IQV US$34.8b
    Zoetis Inc ZTS US$31.9b
    Agilent Tech... A US$37.9b
    Thermo Fishe... TMO US$196.1b

    Net Margin

    Score 4.63/5
    IQVIA Holdings Inc commands a high score, propelled by its net margin consistently outpacing the sector median value and exhibiting continuous growth in recent six years; noteworthy counterparts in the sector, boasting similarly high scores, include Zoetis Inc Agilent Technologies Inc Thermo Fisher Scientific Inc
    IQVIA Holdin... IQV US$34.8b
    Zoetis Inc ZTS US$31.9b
    Agilent Tech... A US$37.9b
    Thermo Fishe... TMO US$196.1b

    Share Buyback

    In Diagnostics & Research industry , Agilent Technologies Inc , Thermo Fisher Scientific Inc , Medpace Holdings Inc are companies with high ratings.

    Leverage

    Score 1.25/5
    IQVIA Holdings Inc registers a lower score in the category as a result of its elevated leverage ratio over the past six years compared to the sector median value. Conversely, other companies in the same sector, including Zoetis Inc Agilent Technologies Inc Thermo Fisher Scientific Inc have achieved high scores.
    IQVIA Holdin... IQV US$34.8b
    Zoetis Inc ZTS US$31.9b
    Agilent Tech... A US$37.9b
    Thermo Fishe... TMO US$196.1b

    Financial Statements

    Company-reported SEC EDGAR facts organized into the three core statements.

    Verified SEC statements load when this section enters view.

    Source: SEC EDGAR companyfacts. Values are standardized company filings for research support, not personalized financial advice.

    Financial Ratio

    Yearly Quarterly

    Financial
    Profitability
    Growth
    Cash Flow
    Financial Health
    Efficiency Ratios

    IQVIA Holdings Inc logo

    IQVIA Holdings Inc

    US$209.16

    US$125.20

    -40.1% vs price

    US$34.8b

    1.23%

    4.10%